Miriam E Jiménez-Maldonado, Edgar R Valdivia-Tangarife, Miguel Ángel Macías-Islas, Fernando Cortés-Enríquez, Alejandra Morlett-Paredes, Fabiola Gonzalez-Ponce, Mario A Mireles-Ramírez, Jazmin Marquez-Pedroza, Nayeli A Sánchez-Rosales, Jorge I Gámez-Nava, Laura González-López, Teresita Villaseñor-Cabrera
{"title":"A review of the validation of the Brief Cognitive Assessment for Multiple Sclerosis in Latin America.","authors":"Miriam E Jiménez-Maldonado, Edgar R Valdivia-Tangarife, Miguel Ángel Macías-Islas, Fernando Cortés-Enríquez, Alejandra Morlett-Paredes, Fabiola Gonzalez-Ponce, Mario A Mireles-Ramírez, Jazmin Marquez-Pedroza, Nayeli A Sánchez-Rosales, Jorge I Gámez-Nava, Laura González-López, Teresita Villaseñor-Cabrera","doi":"10.1177/20552173251350724","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The present review aimed to identify published studies that reported the validation of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) in Latin America (LATAM).</p><p><strong>Methods: </strong>To compile a comprehensive list of available validation studies, we performed a systematic review of the literature via an electronic search of PubMed and Web of Science via the keywords \"Validation,\" \"Brief Cognitive Assessment for Multiple Sclerosis,\" \"BICAMS,\" and \"Latin America.\"</p><p><strong>Results: </strong>Twenty-seven sources of validation studies for the BICAMS were identified. Of the 27 citations identified, only four provide validation of the BICAMS in LATAM. These studies include a comparison of cognitive performance between multiple sclerosis (MS) patients and healthy controls (HCs) across all three BICAMS tests. Overall, the studies included a greater proportion of patients with RRMS and middle-aged adults and included participants with wide ranges of education levels.</p><p><strong>Conclusion: </strong>We provide a detailed description of the BICAMS validation currently available for people living in LATAM. Although the validation of tests in diverse populations has gained interest in the field, there is still a need for more studies among people from LATAM countries.</p>","PeriodicalId":18961,"journal":{"name":"Multiple Sclerosis Journal - Experimental, Translational and Clinical","volume":"11 2","pages":"20552173251350724"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179470/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis Journal - Experimental, Translational and Clinical","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20552173251350724","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The present review aimed to identify published studies that reported the validation of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) in Latin America (LATAM).
Methods: To compile a comprehensive list of available validation studies, we performed a systematic review of the literature via an electronic search of PubMed and Web of Science via the keywords "Validation," "Brief Cognitive Assessment for Multiple Sclerosis," "BICAMS," and "Latin America."
Results: Twenty-seven sources of validation studies for the BICAMS were identified. Of the 27 citations identified, only four provide validation of the BICAMS in LATAM. These studies include a comparison of cognitive performance between multiple sclerosis (MS) patients and healthy controls (HCs) across all three BICAMS tests. Overall, the studies included a greater proportion of patients with RRMS and middle-aged adults and included participants with wide ranges of education levels.
Conclusion: We provide a detailed description of the BICAMS validation currently available for people living in LATAM. Although the validation of tests in diverse populations has gained interest in the field, there is still a need for more studies among people from LATAM countries.
背景:本综述旨在确定拉丁美洲(LATAM)多发性硬化症简短认知评估(BICAMS)验证的已发表研究。方法:为了编制一份全面的可用验证研究列表,我们通过PubMed和Web of Science的电子搜索,通过关键词“验证”、“多发性硬化症简短认知评估”、“BICAMS”和“拉丁美洲”,对文献进行了系统的回顾。结果:确定了27个BICAMS验证研究来源。在鉴定的27个引用中,只有4个在拉丁美洲提供了BICAMS的验证。这些研究包括通过所有三项BICAMS测试比较多发性硬化症(MS)患者和健康对照(hc)之间的认知表现。总的来说,这些研究包括了更大比例的RRMS患者和中年人,并且包括了不同教育水平的参与者。结论:我们提供了目前居住在拉丁美洲的人们可用的BICAMS验证的详细描述。尽管在不同人群中验证测试引起了人们对该领域的兴趣,但仍需要在拉丁美洲国家的人群中进行更多的研究。